GT Biopharma, Inc. (GTBP)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
0. 33
+0.01
+3.1173%
$
3.67M Market Cap
- P/E Ratio
- Div Yield
366,399 Volume
-10.8 Eps
$ 0.32
Previous Close 
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GT Biopharma, Inc. (GTBP) Statistics
Valuation metrics
Market Cap 3.67M
Enterprise value -5.48M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 1.3
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 464.73K
Average volume (90 days) 1.68M
Price summary
52-Week low 0.26
52-Week high 2.21
Beta -
50-Day moving average 0.39
200-Day moving average 0.47
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 5 Feb 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -4.78%
Return on equity -9.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.58
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.29
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.69%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
